?Lotilaner | USP/EP-Certified Parasiticide API | Bulk Supplier for Pet Parasite Control?
?Google Keywords?: Lotilaner bulk supplier, GABA receptor antagonist API, flea and tick treatment, USP-certified veterinary API

?? ?Product Overview?

Lotilaner (CAS 1369852-71-0) is a non-competitive antagonist targeting insect GABA_Cl receptors, specifically effective against fleas, ticks, and mites in pets?13. It disrupts neurotransmission in parasites, leading to rapid paralysis and death?13. Approved for veterinary use in dogs and cats, it is a key ingredient in commercial antiparasitic formulations?15.

?? ?Key Advantages?

• ?High Purity?: ≥99% HPLC purity compliant with ?USP/EP? standards?14.

• ?Bulk Packaging?: Available in 1g–25kg batches with COA, MSDS, and stability testing?12.

• ?Solubility?: White crystalline powder soluble in DMSO (up to 25 mg/ml) for oral or topical formulations?13.

?? ?Applications?

• ?Flea & Tick Control?: Primary treatment in topical/oral pet medications?13.

• ?Veterinary Pharmaceuticals?: Formulated for dogs and cats to prevent parasitic infestations?14.

• ?Research?: Reference standard for studying insecticide resistance mechanisms?35.

?? ?Quality Compliance?

• Certified under ?USP/EP? guidelines with residual solvents <10ppm and heavy metals <20ppm?14.

• Stability tested for 24 months at -20°C in airtight, light-protected containers?14.

?? ?Market Trends?

The global pet parasite treatment market is projected to grow at ?6.8% CAGR (2025-2030)?, driven by rising pet ownership and demand for safe, fast-acting solutions like Lotilaner?13. Its selective action on insect GABA receptors ensures minimal impact on mammals?13.